Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

B3 Consulting Group: No one is immune against a weak market - ABG

B3 Consulting Group

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Sales -3% vs. ABGSCe, adj. EBIT -28% vs. ABGSCe
Drop in utilisation lowered sales by ~8% y-o-y alone
Proactive in stopping underperforming start-ups


Q4'23 report

B3 generated Q4'23 net sales of SEK 294m (-3% vs. ABGSCe 302m) and adj. EBIT SEK ~17m (-28% vs. ABGSCe 24m). Compared to FactSet consensus estimates, reported sales was 1% above while adj. EBIT was 10% below. This quarter was characterised by the same factors that adversely impacted Q3 figures: low utilisation, which in turn is driven by low, general demand. The proposed dividend per share was SEK 3.5 (vs. ABGSCe SEK 4.5, cons. SEK 4.0), implying a similar dividend yield to Knowit.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team